Notice: This company has been marked as potentially delisted and may not be actively trading. G1 Therapeutics (GTHX) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends G1 Therapeutics (NASDAQ:GTHX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.11%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$206,903.47 Get GTHX Insider Trade Alerts Want to know when executives and insiders are buying or selling G1 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GTHX Insider Buying and Selling by Quarter G1 Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/5/2024Andrew PerryInsiderSell1,337$2.51$3,355.87 7/5/2024John E (Jack) Jr. BaileyCEOSell7,662$2.51$19,231.62 7/5/2024John W V UmsteadCFOSell527$2.51$1,322.77 7/5/2024Terry L MurdockCOOSell2,475$2.51$6,212.25 5/23/2024Monica R ThomasInsiderSell5,826$4.27$24,877.02 3/18/2024John W V UmsteadCFOSell6,547$3.02$19,771.94 2/12/2024Rajesh MalikInsiderSell28,600$4.62$132,132.00 (Data available from 1/1/2013 forward) GTHX Insider Trading Activity - Frequently Asked Questions Who is on G1 Therapeutics's Insider Roster? The list of insiders at G1 Therapeutics includes Andrew Perry, Jennifer K Moses, John E (Jack) Jr. Bailey, John W V Umstead, Mark A Velleca, Monica R Thomas, Rajesh Malik, and Terry L Murdock. Learn more on insiders at GTHX. What percentage of G1 Therapeutics stock is owned by insiders? 6.11% of G1 Therapeutics stock is owned by insiders. Learn more on GTHX's insider holdings. Which G1 Therapeutics insiders have been selling company stock? The following insiders have sold GTHX shares in the last 24 months: Andrew Perry ($4,225.62), John E (Jack) Jr. Bailey ($133,747.58), John W V Umstead ($21,421.05), Monica R Thomas ($24,877.02), Rajesh Malik ($256,942.27), and Terry L Murdock ($11,666.44). How much insider selling is happening at G1 Therapeutics? Insiders have sold a total of 128,082 G1 Therapeutics shares in the last 24 months for a total of $452,879.98 sold. G1 Therapeutics Key ExecutivesMr. John E. Bailey Jr. (Age 59)CEO, President & Director Compensation: $1.06MMr. Mark Avagliano (Age 48)Chief Business Officer Compensation: $628.54kMr. John W. Umstead V (Age 39)Chief Financial Officer Mr. Terry L. Murdock (Age 64)Chief Operating Officer Compensation: $541.59kMr. William C. Roberts (Age 55)Vice President of Investor Relations & Corporate Communications Ms. Monica R. ThomasGeneral Counsel & Chief Compliance OfficerMr. Evan Hicks M.B.A.Vice President of MarketingDr. Rajesh K. Malik Ch.B. (Age 65)M.B., M.D., Chief Medical Officer Compensation: $596.37kMr. Andrew Perry (Age 51)Chief Commercial Officer Compensation: $568.6kMr. Jeff MacdonaldSenior Director of Investor Relations & Corporate Communications More Insider Trading Tools from MarketBeat Related Companies Structure Therapeutics Insider Ownership Immunocore Insider Ownership Travere Therapeutics Insider Ownership Schrödinger Insider Ownership Vir Biotechnology Insider Ownership Xencor Insider Ownership Ardelyx Insider Ownership Nurix Therapeutics Insider Ownership Kiniksa Pharmaceuticals Insider Ownership Arcus Biosciences Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:GTHX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G1 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share G1 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
